Cargando…
Effects of psilocybin-assisted therapy on treatment-resistant depression
INTRODUCTION: Major depressive disorder is a highly prevalent clinical condition, affecting more than 300 million individuals worldwide. About 1/3 of patients with MDD fail to achieve remission despite treatment with multiple antidepressants and are considered to have treatment-resistant depression...
Autores principales: | Fraga, A., Esteves-Sousa, D., Facucho-Oliveira, J., Albuquerque, M., Costa, M., Dos Santos, P. Espada, Moura, N., Moutinho, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480034/ http://dx.doi.org/10.1192/j.eurpsy.2021.1836 |
Ejemplares similares
-
The role of intranasal esketamine in treatment-resistant depression
por: Fraga, A., et al.
Publicado: (2021) -
Mechanisms linking gut microbiota to depression
por: Fraga, A., et al.
Publicado: (2021) -
The role of Mediterranean Diet in mental health in pandemic times
por: Fraga, A., et al.
Publicado: (2021) -
The Role of Vagus Nerve Stimulation in Depression: What We Know?
por: Fraga, A., et al.
Publicado: (2022) -
Irritable Bowel Syndrome: The role of the Psychiatry
por: Fraga, A., et al.
Publicado: (2022)